Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (353)
  • Slides (70)
Videos
Podcast
  • Daily News
  • Industry News
  • Conference News
  • Features
  • TCT (87)
  • EuroPCR (17)
  • ACC (9)
  • AHA (6)
  • ESC (6)
  • Cell Therapy (2)
  • Advances in Hemodynamic Support (1)
  • CRT (1)
  • ICI (1)
  • PCR London Valves (1)
  • Coronary (92)
  • DES/BRS/DCB (65)
  • ACS/AMI (56)
  • Aortic Valve (38)
  • Structural Heart (30)
  • CAD Pharma (25)
  • OCT (20)
  • Cardiac Surgery (19)
  • Clinical Cardiology (18)
  • Plaque Modification (13)
  • Policy & Practice (13)
  • Popliteal/Infrapopliteal (12)
  • Angiography/QCA (11)
  • Stroke (11)
  • Mitral Valve (10)
  • CT/CT-FFR (9)
  • Heart Failure (9)
  • Left Atrial Appendage (9)
  • Women's Heart (8)
  • Imaging & Physiology (7)
  • Carotid (6)
  • Endovascular (6)
  • IVUS/NIRS (6)
  • Aortic (5)
  • Lipids (5)
  • Tricuspid Valve (5)
  • Vascular Access/Closure (5)
  • Atrial Fibrillation (4)
  • Guidelines (4)
  • Heart Rhythm (4)
  • Heart Rhythm Pharma (4)
  • Clinical Pharma (3)
  • CTO (3)
  • Diabetes (3)
  • FFR (3)
  • Hypertrophic Cardiomyopathy (2)
  • Venous (2)
  • Femoral (1)
  • Heart Failure Pharma (1)
  • Hypertension (1)
  • MRI (1)
  • PFO/ASD (1)
  • Training (1)
  • (-) 2016 (423)
Displaying 81 - 100 of 423
Sort: Relevancy | Date
MASTER: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction
Presentation TCT 2015

MASTER: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction

Presenter: Bernard J. Gersh, Thomas F. Luscher, Cesar Moris
October 14, 2015
TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease – Five-Year Outcomes
Presentation TCT 2015

TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease – Five-Year Outcomes

Presenter: Bernard J. Gersh, Thomas F. Luscher, Clemens von Birgelen
October 14, 2015
MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement
Presentation TCT 2015

MISTRAL C: A Prospective Randomized Trial of Embolic Protection During Transcatheter Aortic Valve Replacement

Presenter: Bernard J. Gersh, Thomas F. Luscher, Nicolas M. Van Mieghem
October 14, 2015
PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics
Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Bo Xu
October 14, 2015
News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015
News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015
TOTAL: A Prospective Randomized Trial of Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction - One-Year Outcomes
Presentation TCT 2015

TOTAL: A Prospective Randomized Trial of Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction - One-Year Outcomes

Presenter: Sunil V. Rao, Sanjit S. Jolly
October 13, 2015
RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention
Presentation TCT 2015

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Sunil V. Rao, Giora Weisz
October 13, 2015
EXPLORE: A Prospective Randomized Trial of Chronic Total Occlusion Intervention Versus Medical Therapy After Successful Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction
Presentation TCT 2015

EXPLORE: A Prospective Randomized Trial of Chronic Total Occlusion Intervention Versus Medical Therapy After Successful Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction

Presenter: Sunil V. Rao, Jose P.S. Henriques
October 13, 2015
INNOVATION: A Prospective Randomized Trial of Primary Versus Deferred Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction
Presentation TCT 2015

INNOVATION: A Prospective Randomized Trial of Primary Versus Deferred Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

Presenter: David P. Faxon, David O. Williams, Cheol Woong Yu
October 13, 2015
SORT-OUT VI: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Bioabsorbable-Polymer Biolimus-Eluting Stent in Patients With Coronary Artery Disease – Three-Year Outcomes
Presentation TCT 2015

SORT-OUT VI: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Bioabsorbable-Polymer Biolimus-Eluting Stent in Patients With Coronary Artery Disease – Three-Year Outcomes

Presenter: David P. Faxon, David O. Williams, Bent Raungaard
October 13, 2015
News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015
ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes
Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Presenter: Ioanna Kosmidou, Bernard R. Chevalier
October 12, 2015
ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease
Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Dean J. Kereiakes
October 12, 2015
CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease – Two-Year Outcomes
Presentation TCT 2015

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease – Two-Year Outcomes

Presenter: Spencer B. King III, Jagat Narula, Shigeru Saito
October 12, 2015
DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)”
Presentation TCT 2015

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)”

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr
October 12, 2015
ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease
Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes
October 12, 2015
ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease
Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Bernard Chevalier
October 12, 2015
News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015
News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing